Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Heplisav-B × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 1079 Specimen Handling 719 Carboplatin 709 Cyclophosphamide 695 Magnetic Resonance Spectroscopy 674 Cisplatin 609 Nivolumab 588 Paclitaxel 534 Radiotherapy 480 Gemcitabine 469 Biopsy 438 Bevacizumab 398 Dexamethasone 387 fludarabine 345 Docetaxel 338 venetoclax 332 Oxaliplatin 312 atezolizumab 312 Capecitabine 310 Fluorouracil 308 Rituximab 299 durvalumab 287 Radiosurgery 269 Doxorubicin 265 Pemetrexed 263 Drug Therapy 261 Ipilimumab 261 Standard of Care 251 Radiation 248 Lenalidomide 244

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡